
Kinnate Biopharma Inc.
USD2.65
-0.01 (-0.38%)
CEO
Nima Farzan
IPO Date
2020-12-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.65
Prev. Close
$2.66
Day Low
$2.64
Day High
$2.67
52W Low
$1.04
52W High
$7.18
Market Cap
$0.12B
Volume
2.12M
| 19 Sept 2023 |
| Jefferies |
| Buy |
| Buy |
| maintain |
| 19 Sept 2023 | Piper Sandler | Overweight | Neutral | downgrade |
| 19 Sept 2023 | Wedbush | Outperform | Neutral | downgrade |
| 18 Sept 2023 | Jefferies | Buy | Buy | maintain |
| 18 Sept 2023 | Piper Sandler | Overweight | Neutral | downgrade |
| 18 Sept 2023 | HC Wainwright & Co. | Buy | Neutral | downgrade |
| 18 Sept 2023 | Wedbush | Outperform | Neutral | downgrade |